Type 2 diabetes risk: early warning signs and how to test before it's too late

Insulin resistance: the foundational mechanism

Type 2 diabetes does not begin with high blood sugar. It begins with insulin resistance: a state in which the body's cells become progressively less responsive to the insulin signal, requiring the pancreas to produce increasingly large amounts of insulin to keep blood glucose in range. In the early stages of insulin resistance, blood glucose can remain normal because the pancreas compensates. This compensatory hyperinsulinaemia (persistently elevated insulin) is itself damaging to blood vessels and metabolic function, and it is often invisible on standard tests that measure glucose alone. Over time, as the pancreas becomes unable to sustain this output, glucose starts to rise and prediabetes becomes detectable.

Excess adiposity and visceral fat

Visceral fat, the fat stored around abdominal organs rather than subcutaneously, is metabolically active in ways that directly impair insulin signalling. It releases inflammatory cytokines and free fatty acids that interfere with insulin receptor function in the liver, muscle, and adipose tissue, driving insulin resistance at a cellular level. The relationship between visceral fat and metabolic risk is stronger than body weight alone, which means people with a normal BMI but significant central adiposity can carry significant metabolic risk that standard weight-based screening does not capture. Lipid markers (particularly triglycerides and the triglyceride-to-HDL ratio) correlate closely with visceral fat and are measurable through a standard blood panel.

Sedentary behaviour and muscle mass

Skeletal muscle is the body's primary site of glucose uptake. Regular muscular activity, particularly resistance exercise, directly improves insulin sensitivity by increasing glucose transporter expression in muscle cells. Prolonged sedentary behaviour reduces this capacity. The relationship is not purely about exercise volume: even breaking up long periods of sitting with brief movement significantly improves post-meal glucose control. Muscle mass declines with age (sarcopenia), and people with lower relative muscle mass have a significantly higher risk of insulin resistance and type 2 diabetes regardless of body weight.

Dietary patterns and glycaemic load

Persistently high dietary glycaemic load, driven by refined carbohydrates, ultra-processed foods, and high-sugar beverages, creates repeated large demands on insulin production and accelerates the trajectory towards insulin resistance. This is not about individual foods in isolation: the overall pattern of a diet high in refined carbohydrates, low in fibre, and low in protein and healthy fats creates the conditions for metabolic dysfunction over time. Conversely, dietary patterns that prioritise whole foods, reduce glycaemic variability, and maintain adequate protein and fibre intake have strong evidence for reducing diabetes risk.

Sleep disruption and the metabolic consequences

Poor sleep, including both short duration and fragmented quality, has a direct and dose-dependent effect on insulin sensitivity. A single night of insufficient sleep can reduce insulin sensitivity by 25% in healthy adults; chronic sleep disruption compounds this effect alongside increasing appetite-regulating hormones (ghrelin rises, leptin falls) that drive overconsumption of energy-dense foods. This creates a bidirectional cycle: poor metabolic health disrupts sleep, and poor sleep worsens metabolic health. Addressing sleep quality is not secondary to dietary and exercise interventions in metabolic health; it is comparable in impact.

Chronic stress and cortisol elevation

Cortisol (the primary stress hormone) raises blood glucose through gluconeogenesis in the liver and reduces peripheral insulin sensitivity. Chronically elevated cortisol, driven by sustained psychological or physiological stress, maintains blood glucose at a level that would not occur under normal conditions. People under significant occupational or personal stress, or those with disrupted HPA axis function, may find that standard dietary and exercise interventions produce less improvement than expected because cortisol is consistently undermining their effect. Measuring inflammatory markers alongside standard glucose markers gives a broader view of whether stress-related inflammation is a contributing factor.

Genetics and family history

Having a first-degree relative with type 2 diabetes approximately doubles the lifetime risk. Several genetic variants affecting insulin secretion, insulin sensitivity, and fat distribution contribute to this inherited risk. Genetics do not determine outcome, but they set the starting point: someone with a strong family history is starting from a lower threshold for metabolic dysfunction and needs a proportionally smaller environmental burden to cross into prediabetes territory. This is why monitoring biomarkers proactively is particularly valuable for people with a family history of type 2 diabetes, even in the absence of obvious symptoms.

The NHS currently offers diabetes risk assessment through NHS Health Checks (for those aged 40 to 74) and targeted screening for high-risk groups. The primary test used is HbA1c. NICE defines prediabetes as an HbA1c of 42 to 47 mmol/mol and type 2 diabetes as 48 mmol/mol or above. However, HbA1c has limitations: it can miss early insulin resistance (where glucose is still controlled but at the cost of elevated insulin), and it can be affected by conditions that alter red blood cell turnover. A more complete metabolic assessment looks beyond HbA1c to include lipid markers, inflammatory markers, and patterns across multiple biomarkers that together reflect the quality of blood sugar control and the degree of metabolic stress.

For people with a family history of type 2 diabetes, a BMI above 25, South Asian or African-Caribbean ethnicity, a history of gestational diabetes, or persistent symptoms (fatigue, increased thirst, frequent urination, or unexplained weight changes), a proactive comprehensive blood panel is a practical way to establish your current metabolic position before clinical thresholds are reached.

For those who want to assess active insulin resistance specifically, fasting insulin and a calculated HOMA-IR score provide the most direct window into whether the pancreas is compensating for insulin resistance at the time of testing. These are available through your GP in some settings or through a private laboratory. If your Optimal Bloods results show borderline HbA1c, elevated triglycerides, or low HDL alongside symptoms of metabolic dysfunction, discussing fasting insulin testing with your practitioner is a logical next step.

Diet: reducing glycaemic load and improving food quality

The most evidence-supported dietary interventions for reducing diabetes risk centre on improving food quality rather than counting calories. Replacing refined carbohydrates with whole grain alternatives, legumes, vegetables, and protein reduces the glycaemic demand placed on the insulin system. Dietary fibre (from vegetables, fruit, pulses, and wholegrains) slows glucose absorption and feeds gut bacteria that produce short-chain fatty acids with insulin-sensitising effects. Reducing ultra-processed food consumption has independent metabolic benefits beyond its effect on caloric intake. Tracking HbA1c at regular intervals is the most reliable way to confirm whether dietary changes are producing the expected metabolic shift for your biology.

Exercise: prioritising muscle and breaking sedentary time

Both aerobic exercise and resistance training independently improve insulin sensitivity, but through different mechanisms. Aerobic activity increases glucose uptake in working muscles and reduces hepatic glucose output. Resistance training builds muscle mass and increases the total tissue available for glucose disposal. The combination of both, structured as a consistent weekly practice, produces the largest and most durable reduction in metabolic risk. Breaking up long periods of sitting with even brief bouts of light movement (such as a 10-minute walk after meals) has well-documented effects on post-meal glucose control and is additive to formal exercise.

Sleep optimisation

Targeting seven to nine hours of consistent, good-quality sleep is among the highest-leverage interventions for metabolic health. Sleep is when insulin sensitivity resets, growth hormone (which supports muscle repair and metabolic regulation) is secreted, and cortisol reaches its lowest point. Prioritising sleep timing (consistent bed and wake times), sleep environment (cool, dark, quiet), and addressing sleep quality issues (including assessment for sleep apnoea in those with relevant risk factors) creates metabolic conditions that dietary and exercise interventions build on rather than fight against.

Stress regulation and cortisol management

Structural approaches to stress management, including regular exercise, adequate recovery time, social connection, and practised relaxation techniques, measurably reduce cortisol output and improve HPA axis regulation over time. These are not ancillary lifestyle suggestions: they directly affect the hormonal environment in which glucose regulation occurs. Monitoring CRP over time gives a practical signal for whether the inflammatory burden from stress is being reduced alongside the lifestyle changes being made.